Klaria Pharma wins EU patent approval for Sumatriptan Alginate Film portfolio###

• Klaria Pharma Holding AB received notice from the European Patent Office that its second Sumatriptan Alginate Film patent will be granted in full.
• The additional patent extends EU protection for the product, supporting manufacturing flexibility and strengthening enforcement against potential infringement.
• Klaria also cited a positive novelty and inventive-step opinion for a third patent in the same family, targeting protection through 2045.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 202608070421BITN____UKPR__SV_20260807-BIT-5321-0) on August 07, 2026, and is solely responsible for the information contained therein.